Full Text (PDF)
Case Report

Combination Therapy for Acute Management of Yellow Oleander Poisoning: A Case Report

Mohammed Ismail Nizami, Mohammed Mubashir Ahmed Subhani, Ashima Sharma, Suneel Kumar G

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Emergency Medicine 8(4):p 149-151, October-December 2022. | DOI: https://doi.org/10.21088/ijem.2395.311X.8422.8

How Cite This Article:

Mohammed Mubashir Ahmed Subhani, Ashima Sharma et al./Combination Therapy for Acute Management of Yellow Oleander Poisoning: A Case Report/Indian J Emerg Med 2022;8(4):149–151.

Timeline

Received : August 04, 2022         Accepted : May 02, 2022          Published : December 25, 2022

Abstract

Ingestion of yellow oleander as a mode of suicide is common in India and Southeast Asia. It is associated with severe cardiac toxicity. A combination therapy is suggested in a resource limited setting as Digoxin specific antibody fragments are not easily available for treatment of serious cardiac glycoside poisoning. Severe atrio-ventricular block can be treated with atropine or temporary cardiac pacing. Ventricular tachycardia can be treated with low dose cardioversionand ventricular fibrillation with low dose defibrillation depending on the presentation.


References

  • 1.   De Silva HA, Fonseka MM, Pathmeswaran A, Alahakone DG, Ratnatilake GA, Gunatilake SB, Ranasinha CD, Lalloo DG, Aronson JK, De Silva HJ. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. The Lancet. 2003 Jun 7;361(9373):1935-8.
  • 2.   Pandit VR, Kadhiravan T, KNJ PR. Cardiac arrhythmias, electrolyte abnormalities and serum cardiac glycoside concentrations in yellow oleander (Cascabelathevetia) poisoning-a prospective study. Clinical toxicology (Philadelphia, Pa.). 2018 Aug 3;57(2):104-11.
  • 3.   Fonseka MM, Seneviratne SL, De Silva CE, Gunatilake SB, De Silva HJ. Yellow oleander poisoning in Sri Lanka: outcome in a secondary care hospital. Human & experimental toxicology. 2002 Jun;21(6):293-5.
  • 4.   Poindexter BJ, Feng W, Dasgupta A, Bick RJ. Oleandrin produces changes in intracellular calcium levels in isolated cardiomyocytes: a real-time fluorescence imaging study comparing adult to neonatal cardiomyocytes. Journal of Toxicology and Environmental Health, Part A. 2007 Feb 13;70(6):568-74.
  • 5.   Rajapakse S. Management of yellow oleander poisoning. Clinical Toxicology. 2009 Mar 1;47(3):206-12.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Mohammed Mubashir Ahmed Subhani, Ashima Sharma et al./Combination Therapy for Acute Management of Yellow Oleander Poisoning: A Case Report/Indian J Emerg Med 2022;8(4):149–151.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
August 04, 2022 May 02, 2022 December 25, 2022

DOI: https://doi.org/10.21088/ijem.2395.311X.8422.8

Keywords

Yellow Oleander PoisoningDigoxin specific antibody fragmentsDefibrillationCardioversion

Article Level Metrics

Last Updated

Monday 06 July 2026, 23:45:17 (IST)


2508

Accesses

3
890
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received August 04, 2022
Accepted May 02, 2022
Published December 25, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share